Blend Labs Inc SEC Filings

Form 144 filed for Blend Labs, Inc. (BLND) reporting a proposed sale of 25,000 common shares through Charles Schwab & Co., Inc. with an approximate aggregate market value of $109,069 and an approximate sale date of 09/15/2025 on the NYSE. The filer shows these 25,000 shares were acquired on 02/17/2020 by exercise and held, with payment in cash. The filing lists prior dispositions by Brian Kneafsey totaling 175,000 shares sold between 06/16/2025 and 08/15/2025 for aggregate gross proceeds of $575,145. The form includes the standard representation that the seller is not aware of undisclosed material adverse information.

Oxana Tkach, Principal Accounting Officer at Blend Labs, Inc. (BLND), reported an insider sale executed under a pre-established Rule 10b5-1 plan. On 09/05/2025 the Form 4 discloses the disposition of 101,429 shares of Class A common stock at a weighted average sale price of $4.0026 per share. Following the reported sales, the filing states the reporting person beneficially owned 52,780 shares as a direct holder. The Form 4 was signed by attorney-in-fact Winnie Ling on 09/09/2025. The filing notes the 10b5-1 plan was adopted on March 14, 2025, and the sale price range realized was $4.00 to $4.005 per share.

Blend Labs insider sale reported. Director Eric H. Woersching sold 20,000 shares of Class A common stock on 09/05/2025 at $4.005 per share under a Rule 10b5-1 trading plan adopted March 4, 2025. After the reported sale he beneficially owns 30,000 shares. The Form 4 was filed by one reporting person and signed by an attorney-in-fact on 09/09/2025. The filing discloses the sale was executed pursuant to an established written plan; no other transactions, grants, or derivative positions are listed.

Blend Labs, Inc. insider transactions: Winnie Ling, Head of Legal and People and an officer of Blend Labs (BLND), reported two open-market sales under a Rule 10b5-1 trading plan adopted March 14, 2025. On 09/04/2025 she sold 4,000 shares at a weighted-average price of $3.5076, leaving 412,631 shares beneficially owned. On 09/05/2025 she sold 17,500 shares at a weighted-average price of $4.0036, leaving 395,131 shares beneficially owned. The Form 4 discloses the weighted-average price ranges for each sale and states the seller will provide detailed per-price allocations upon request.

Blend Labs, Inc. (BLND) filed a Form 144 reporting a proposed sale of 20,000 common shares through Charles Schwab & Co., Inc. with an aggregate market value of $80,100.00. The shares represent a small portion of the company's outstanding common stock of 255,696,747 shares. The filing lists an approximate sale date of 09/05/2025. The shares were acquired on 06/10/2025 by restricted stock lapse from Blend Labs, Inc., and the consideration is listed as equity compensation. No related sales by the same person in the past three months are reported.

Blend Labs, Inc. (BLND) filing a Form 144 notifies the proposed sale of 101,429 shares of common stock with an aggregate market value of $405,980.00. The shares were acquired on 02/20/2024 by lapse of restricted stock as equity compensation from Blend Labs, Inc. The proposed sale is to be effected through Charles Schwab & Co., Inc. on or about 09/05/2025 on the NYSE. Total shares outstanding reported are 255,696,747. The filer certifies they do not possess undisclosed material adverse information about the issuer.

Form 144 notice for Blend Labs, Inc. (BLND) shows a proposed sale of 17,500 common shares via Charles Schwab & Co., Inc. with an aggregate market value of $70,063.00, to be sold on 09/05/2025 on the NYSE. The shares were acquired through restricted stock lapse events on 03/20/2024 (3,597 shares) and 05/20/2024 (13,903 shares) as equity compensation from Blend Labs, Inc. The filer also reported six prior sales by the same person between 07/03/2025 and 09/04/2025, totaling 28,000 shares and gross proceeds of $99,028.00. The notice includes the filer’s statement that they are not aware of undisclosed material adverse information.

Blend Labs insider notice: proposed sale of 4,000 shares. The Form 144 shows 4,000 shares of Blend Labs, Inc. common stock were acquired 02/20/2025 via a restricted stock lapse as equity compensation and are proposed for sale through Charles Schwab & Co., Inc. with an aggregate market value of $14,031 and an approximate sale date of 09/04/2025 on the NYSE. The filing also lists five insider sales by Winnie Ling in the past three months totaling 24,000 shares for $84,997 in gross proceeds, with individual sale dates and proceeds provided in the notice.

Oxana Tkach, Principal Accounting Officer of Blend Labs, Inc. (BLND), reported equity awards and tax-withheld shares related to vested restricted stock units. On 08/20/2025 the filing shows two grant-related transactions: 25,000 RSUs and 12,500 RSUs reported as acquisitions (transaction code M) that increased reported Class A common stock holdings to 164,972 shares before a tax-withholding disposition. A subsequent disposition of 10,763 shares (transaction code F) at a price of $3.01 was made to satisfy taxes, leaving 154,209 shares reported as beneficially owned. The derivative table shows RSU balances of 25,000 and 12,500 that convert one-for-one into Class A shares; the filing states these RSUs vest quarterly over four years and two years, respectively, and that shares were withheld to cover tax obligations.